Cargando…
Angiogenesis and antiangiogenic agents in cervical cancer
Standard treatment of cervical cancer (CC) consists of surgery in the early stages and of chemoradiation in locally advanced disease. Metastatic CC has a poor prognosis and is usually treated with palliative platinum-based chemotherapy. Current chemotherapeutic regimens are associated with significa...
Autores principales: | Tomao, Federica, Papa, Anselmo, Rossi, Luigi, Zaccarelli, Eleonora, Caruso, Davide, Zoratto, Federica, Benedetti Panici, Pierluigi, Tomao, Silverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259513/ https://www.ncbi.nlm.nih.gov/pubmed/25506227 http://dx.doi.org/10.2147/OTT.S68286 |
Ejemplares similares
-
Current status of bevacizumab in advanced ovarian cancer
por: Tomao, Federica, et al.
Publicado: (2013) -
Niraparib in ovarian cancer: results to date and clinical potential
por: Caruso, Davide, et al.
Publicado: (2017) -
Triple-negative breast cancer: new perspectives for targeted therapies
por: Tomao, Federica, et al.
Publicado: (2015) -
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
por: Zoratto, Federica, et al.
Publicado: (2012) -
Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells
por: Tomao, Federica, et al.
Publicado: (2014)